Experts say Johns Hopkins’ patient data could have been stolen by hackers even if security measures were impeccable. So why are so many people suing the institution?
As counties start to see millions trickling in from the state opioid settlement totaling $400 million, Baltimore bides its time in hopes of a larger payout. Will the gamble pay off?
Twelve percent of the 139,000 people up for renewal in June lost their health insurance for preventable reasons, bringing the total of avoidable coverage losses to 42,000 over two months.
One in three shooting deaths involve heavy drinking, but alcohol use is not widely addressed in public policy or violence prevention programs, Johns Hopkins researchers found.
Family members with their own work and family obligations are having to step in, and often cannot provide the level or frequency of care that their loved ones need.
Remote Area Medical’s free pop-up clinic in Northeast Baltimore drew hundreds of people who've fallen through the cracks of Maryland’s fragmented health insurance system.
Twenty one percent of the first Marylanders who've had to renew their Medicaid coverage post-pandemic have lost it because they either did not receive notices or could not overcome administrative hurdles.
The Kahlert Institute for Addiction Medicine will bring together neuroscientists, clinical researchers and substance use specialists to research the causes and treatment of addiction.
Ukrainian President Volodymyr Zelenskyy delivered a surprise address at Johns Hopkins University’s commencement ceremony via livestream Thursday morning.
Moving low-income families out of high-poverty neighborhoods can improve kids’ asthma more than medications do, according to research from the Johns Hopkins University and the Baltimore Regional Housing Partnership.
As the COVID-19 public health emergency ends, Maryland begins the Herculean task of renewing Medicaid coverage for everyone enrolled for the first time in three years.
Gov. Wes Moore’s office said such a plan is coming “as soon as possible” and the administration is “exploring options” such as stockpiling the drug mifepristone.